Technical Program

Thursday, September 20th

INVITED SPEAKER: Defined Composition CD19 CAR-T cells for Adult B cell Malignancies

Cameron Turtle, Fred Hutchinson Cancer Research Center

Tales of Three CAR T Cell Start-Ups 

Ronald Dudek, Lentigen Technology, Inc.

Systematic Investigation of Parameters That Affect In Vivo CAR-T Cell Function

Ximin Chen, University of California, Los Angeles

INVITED SPEAKER: Genetic Engineering Approaches to Improve CAR T Cell Anti-Tumor Activity for Solid Tumors

Giedre Krenciute, St. Jude Childrens Research Hospital

INVITED SPEAKER: Signal Control of CD8 T Cell Immune Responses

Xiaoping Zhong, Duke University School of Medicine

Macrophage-Mediated Delivery of Light Activated Nitric Oxide Prodrugs with Spatial, Temporal and Concentration Control

Michael A. Evans, Harvard University

Tumor Cell Intrinsic Factors Dictate Immune Cell Infiltration and Response to Immunotherapy

Katelyn T. Byrne, Parker Institute for Cancer Immunotherapy

Self-Cancellation Mechanism of the PD-L1/PD-1 Pathway

Enfu Hui, University of California, San Diego

INVITED SPEAKER: Reprogramming Human T Cell Circuitry

Alexander Marson, University of California, San Francisco

Justin Farlow, Co-Founder and CTO, Serotiny, Inc.

Julie Norville, Co-Founder, JURA Bio, Inc.

Elizabeth Wood, Co-Founder, JURA Bio, Inc.

Friday, September 21st

KEYNOTE SPEAKER: Translation of YESCARTA®, a first-in-class CAR T cell product for Non-Hodgkin Lymphoma

Adrian Bot, Kite Pharma

INVITED SPEAKER: Manipulating Tregs to Control Tolerance in Autoimmunity and Cancer

Qizhi Tang, University of California, San Francisco

INVITED SPEAKER: Immunoengineering for Improved Antitumor Immunity

Michael Goldberg, Dana-Farber Cancer Institute

In Vivo Metabolic Labeling and Targeted Modulation of Dendritic Cells for Enhanced Cancer Immunotherapy

Hua Wang, Harvard University

Lentiviral-mediated FOXP3 gene transfer to convert CD4+ T cells to Treg cells: a suitable method for immunotherapy

Rosa Bacchetta, Stanford University

Generation of Antigen-Specific Germinal Center-like B Cells As a Next-Generation Immunotherapy

Hannah Song, Georgia Institute of Technology

INVITED SPEAKER: Adoptive Cell Therapy: Enabling Technologies for Endogenous T Cell (ETC) Therapy of Cancer

Cassian Yee, MD Anderson Cancer Center

Novel Engineering Approaches for Developing Therapeutically Relevant T Cell Receptors for Use in T Cell Therapies for Multiple Sclerosis (MS)

Elissa Leonard, University of Texas at Austin

INVITED SPEAKER: Enhancing T cell Immunotherapy Using Responsive Biomaterials

Li Tang, École polytechnique fédérale de Lausanne (EPFL)

INVITED SPEAKER: In Situ Programming of Therapeutic T Cells Using Synthetic Nanoparticles

Matthias Stephan, University of Washingto, Seattle, WA

Treating Diabetes with a Cup of Coffee

Daniel Bojar, ETH Zurich

Single Use Disposable Biosettler Removes the Dead Cells and Cell Debris Selectively to Increase the Viability Percentage of Mammalian Cells (e.g. CAR-T) during Expansion

Dhinakar Kompala, Sudhin Biopharma Co

Saturday, September 22

INVITED SPEAKER: Improving the expansion and persistence of CAR T-cells for solid tumors

Cliona Rooney, Baylor College of Medicine

INVITED SPEAKER: Towards the development of a dual antigen AND-gate CAR T for prostate cancer

Amy Gilbert, Kite Pharma

Supervised Machine Learning Methods for Chemometric Modeling and Predicting in Biotherapeutic Manufacturing Processes

Thomas Li, Pfizer

Decision Tools in the Assistance of the CAR T-Cell Industry

Maria Papathanasiou, Imperial College, London

Drug Response Landscape of BRAF-Mutated Melanoma Cells: Non-Quiescent "Idling Population State" As an Alternative Drug Persistence

Bishal Paudel, Vanderbilt University

Functionalized Microcarriers for Enhanced CAR T Cell Manufacturing

Nate Dwarshuis, Georgia Institute of Technology

INVITED SPEAKER: Engineering the Next Generation of Immune Cell Therapies

Kole Roybal, University of California, San Francisco

INVITED SPEAKER: Engineering Biological Computers for Human Health Applications

Tim Lu, Massachusetts Institute of Technology

Synthetic Transcriptional Regulation for Human Cell Therapy

Divya Israni, Boston University

Design Driven Engineering of Extracellular Sensors for the Development of Mammalian Cell-Based Therapies

Taylor Dolberg, Northwestern University

Thermal Bioswitches for Noninvasive Control of Cell Function

Dan Piraner, California Institute of Technology